Precision Medicine and Pharmacological Innovation, MSc

Precision Medicine (also known as Stratified, Personalised or Individualised Medicine) aims to improve therapies for patients such that drug treatments are individualised for each patient thus improving his/her likelihood of the best response. This approach has huge potential to enhance therapies and the timely development of new treatments for human disease. It is one of the most important concepts in 21st century clinical science and is a crucial component of the global drive to increase the efficacy, safety and cost effectiveness of new medicines. This taught postgraduate Masters programme harnesses Scotland's strengths in Stratified Medicine, Clinical Trials, Bioinformatics and Pharmacogenomics and draws on the current and future needs of the Life Sciences sector. It has been developed in conjunction with the industrial partners of the Stratified Medicine Scotland Innovation Centre (SMS-IC). Throughout, this programme will integrate basic and clinical sciences and emphasise the important link between these and the biomedical and healthcare industry. You will benefit from focused training and will graduate better equipped to design, execute and evaluate modern clinical interventions. This specially funded programme is open for applicants domiciled in Scotland. Prestigious Scottish Funding Council Awards are available to high calibre applicants for this programme. The awards cover all tuition costs and all you need to do is apply in order to be considered. The MSc Precision Medicine and Pharmacological Innovation is a unique postgraduate degree, offered jointly by the University of Aberdeen, University of Glasgow and University of Strathclyde. Students choose to study on campus at either the University of Aberdeen or University of Glasgow. More details: https://www.abdn.ac.uk/study/postgraduate-taught/degree-programmes/971/stratified-medicine-and-pharmacological-innovation/#stage_2